title: Endocrine aspects of women's sexual function.
abstract: BACKGROUND
  Endocrine changes during aging as well as endocrine disorders may either directly or indirectly modulate female sexual function by altering sex hormones, or by impacting on vascular, neurogenic, or psychologic factors.
  
  
  OBJECTIVE
  To review information on the impact of the hormonal changes associated with aging or those caused by endocrine disorders on female sexual function and current information on the risks and benefits of hormonal treatments.
  
  
  METHODS
  Committee members outlined topics and reviewed the published literature on endocrine aspects of female sexual function over a 2-year period. Presentation of the recommendations were presented at the International Consultation on Sexual Medicine Paris, France 2009 and revised accordingly.
  
  
  METHODS
  Quality of data published in the literature and recommendations were based on the GRADES system.
  
  
  RESULTS
  Recommendations and guidelines concerning the role of sex hormones and endocrine disorders in female sexual function were derived.
  
  
  CONCLUSIONS
  Hormones are only one component of the many factors that contribute to normal sexual function in women. Further research is needed as to the impact of hormones and endocrine disorders on female sexual dysfunction and the benefits and risks of hormonal therapies.
authors.affiliation: University of Colorado at Denver, Medicine, Physiology and Biophysics, Aurora, and Denver Veterans Affairs Medical Center, Endocrinology, Denver, CO, USA. wierman@ucdenver.edu
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Wierman
authors.forename: Rossella E
authors.initials: RE
authors.lastname: Nappi
authors.forename: Nancy
authors.initials: N
authors.lastname: Avis
authors.forename: Susan R
authors.initials: SR
authors.lastname: Davis
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Labrie
authors.forename: Willam
authors.initials: W
authors.lastname: Rosner
authors.forename: Jan L
authors.initials: JL
authors.lastname: Shifren
mesh_terms: D048909:Diabetes Complications / Q000453:epidemiology; D004702:Endocrine Glands / Q000378:metabolism* / Q000503:physiopathology*; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D012735:Sexual Dysfunction, Physiological / Q000453:epidemiology / Q000503:physiopathology*; D013739:Testosterone / Q000378:metabolism*
chemical_list: D004967:Estrogens; D013739:Testosterone